NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: A possible role in neuroprotection?

Molecular and Cellular Biochemistry

Volumn 376, Issue 1-2, 2013, Pages 189-195

  Croce, Nicoletta ^a   Gelfo, Francesca ^a   Ciotti, Maria Teresa ^b   Federici, Giorgio ^c   Caltagirone, Carlo ^a   Bernardini, Sergio ^c   Angelucci, Francesco ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Alzheimer disease; BDNF; miR 30a 5p; NPY; Primary cortical neurons

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; BRAIN DERIVED NEUROTROPHIC FACTOR; MICRORNA; MICRORNA 30A 5P; NEUROPEPTIDE Y; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; FETUS; IN VITRO STUDY; INCUBATION TIME; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BASE SEQUENCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CEREBELLAR CORTEX; GENE EXPRESSION REGULATION; MICRORNAS; MOLECULAR SEQUENCE DATA; NEURONS; NEUROPEPTIDE Y; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

RATTUS;

EID: 84874256361     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1567-0     Document Type: Article

References (34)

1. Finch CE, Cohen DM (1997) Aging, metabolism, and Alzheimer disease: review and hypotheses. Exp Neurol 143:82-102. doi: 10.1006/exnr.1996.6339
2. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890. doi: 10.1016/S0006-291X(84)80190-4
3. Bramham CR, Messaoudi E (2005) BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76:99-125. doi: 10.1016/j.pneurobio.2005.06.003
4. Murer MG, Yan Q, Raisman-Vozari R (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63:71-124. doi: 10.1016/S0301-0082(00)00014-9
5. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow YW (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7:695-702. doi: 10.1016/0896-6273(91)90273-3
6. Connor B, Young D, Yan Q, Faull QRLM, Synek B, Dragunow M (1997) Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Mol Brain Res 49:71-81. doi: 10.1016/S0169-328X(97)00125-3
7. Angelucci F, Spalletta G, Iulio FD, Ciaramella A, Salani F, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Bossu P (2010) Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF serum levels. Curr Alzheimer Res 7:15-20. doi: 10.2174/156720510790274473
8. Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S (2008) New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev 59:201-220. doi: 10.1016/j.brainresrev.2008.07.007
9. Laske C, Stellos K, Hoffmann N, Stransky E, Straten G, Eschweiler GW, Leyhe T (2011) Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. Int J Neuropsychopharmacol 14:399-404. doi: 10.1017/S1461145710001008
10. Croce N, Dinallo V, Ricci V, Federici G, Caltagirone C, Bernardini S, Angelucci F (2011) Neuroprotective effect of neuropeptide Y against beta-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production. Neurodener Dis 8:300-309. doi: 10.1159/000323468
11. Rose JB, Crews L, Rockenstein E, Adame A, Mante M, Hersh LB, Gage FH, Spencer B, Potkar R, Marr RA, Masliah E (2009) Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease. J Neurosci 29:1115-1125. doi: 10.1523/JNEUROSCI.4220-08. 2009
12. Croce N, Ciotti MT, Gelfo F, Cortelli S, Federici G, Caltagirone C, Bernardini S, Angelucci F (2012) Neuropeptide Y protects rat cortical neurons against beta-amyloid toxicity and re-establishes synthesis and release of nerve growth factor. ACS Chem Neurosci 3:312-318. doi: 10.1021/cn200127e
13. Numakawa T, Richards M, Adachi N, Kishi S, Kunugi H, Hashido K (2011) MicroRNA function and neurotrophin BDNF. Neurochem Int 59:551-558. doi: 10.1016/j.neuint.2011.06.009
14. Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S (2008) A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet 17:3030-3042. doi: 10.1093/hmg/ddn201
15. di Penta A, Mercaldo V, Florenzano F, Munck S, Ciotti MT, Zalfa F, Mercanti D, Molinari M, Bagni C, Achsel T (2009) Dendritic LSm1/CBP80-mRNPs mark the early steps of transport commitment and translational control. J Cell Biol 184:423-435. doi: 10.1083/jcb.200807033
16. Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS (1995) The toxicity in vitro of beta-amyloid protein. Biochem J 311:1-16
17. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW (1995) Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 64:253-265. doi: 10.1046/j.1471-4159.1995.64010253.x
18. Shearman MS, Ragan CI, Iversen LL (1994) Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid- mediated cell death. Proc Natl Acad Sci USA 91:1470-1474. doi: 10.1073/pnas.91.4.1470
19. Terzi E, Holzemann G, Seelig J (1994) Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35). Biochemistry 33:1345-1350. doi: 10.1021/bi00172a009
20. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA (1994) A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA 91:3270-3274. doi: 10.1073/pnas.91.8.3270
21. Hansel DE, Eipper BA, Ronnett GV (2001) Neuropeptide Y functions as a neuroproliferative factor. Nature 410:940-944. doi: 10.1038/35073601
22. Zukowska-Grojec Z, Pruszczyk P, Colton C, Yao J, Shen GH, Myers AK, Wahlestedt C (1993) Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides 14:263-268. doi: 10.1016/0196-9781(93)90040-N
23. Protas L, Qu J, Robinson RB (2003) Neuropeptide Y: neurotransmitter or trophic factor in the heart? News Physiol Sci 18:181-185
24. Zhao S, Fernald RD (2005) Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 12:1045-1062. doi: 10.1089/cmb.2005.12.1047
25. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102-114. doi: 10.1038/nrg2290
26. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297. doi: 10.1016/S0092-8674(04)00045-5
27. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, Greenberg ME (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289. doi: 10.1038/nature04367
28. Hébert SS, Horré K, Nicolaï L, Bergmans B, Papadopoulou AS, Delacourte A, De Strooper B (2009) MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 33:422-428. doi: 10.1016/j.nbd.2008.11.009
29. Fang M, Wang J, Zhang X, Geng Y, Hu Z, Rudd JA, Ling S, Chen W, Han S (2012) The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease. Toxicol Lett 209:94-105
30. Lukiw WJ, Alexandrov PN (2012) Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol Neurobiol 46:11-19. doi: 10.1007/s12035-012-8234-4
31. Ghosh A, Carnahan J, Greenberg ME (1994) Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263:1618-1623. doi: 10.1126/science.7907431
32. Liu H, Liu Z, Xu X, Yang X, Wang H, Li Z (2010) Nerve growth factor regulates galanin and neuropeptide Y expression in primary cultured superior cervical ganglion neurons. Pharmazie 65:219-223
33. Yoshimura R, Ito K, Endo Y (2009) Differentiation/maturation of neuropeptide Y neurons in the corpus callosum is promoted by brain-derived neurotrophic factor in mouse brain slice cultures. Neurosci Lett 450:262-265. doi: 10.1016/j.neulet.2008.12.010
34. Mellios N, Huang H-S, Baker SP, Galdzicka M, Ginns E, Akbarian S (2009) Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 65:1006-1014. doi: 10.1016/j.biopsych.2008.11.019